Publikationstyp: Beitrag in wissenschaftlicher Zeitschrift
Art der Begutachtung: Peer review (Publikation)
Titel: Preventable spina bifida and anencephaly in Europe
Autor/-in: Obeid, Rima
Pietrzik, Klaus
Oakley, Godfrey
Kancherla, Vijaya
Holzgreve, Wolfgang
Wieser, Simon
DOI: 10.1002/bdra.23400
Erschienen in: Birth Defects Research
Band(Heft): 103
Heft: 9
Seite(n): 763
Seiten bis: 771
Erscheinungsdatum: 2015
Verlag / Hrsg. Institution: Wiley
ISSN: 1542-0752
1542-0760
Sprache: Englisch
Schlagwörter: Anencephaly; Economic; Folic acid; Fortification; Neural tube defects; Pregnancy; Prevention; Spina bifida; Anencephaly; Dietary Supplements; Ethnic Groups; Europe; European Continental Ancestry Group; Female; Folic Acid; Food, Fortified; Humans; Live Birth; Pregnancy; Prevalence; Spinal Dysraphism
Fachgebiet (DDC): 616.7: Krankheiten des Bewegungsapparates und Orthopädie
Zusammenfassung: Background: Promotion of voluntary folic acid supplement use among women of reproductive age has been proven to be ineffective in lowering the risk of neural tube defects in Europe. Methods: Using surveillance data from all births covered by the full member countries of the European Surveillance of Congenital Anomalies (EUROCAT), we estimated the total prevalence of spina bifida and anencephaly per 10,000 births between 2000 and 2010. We also estimated additional lifetime direct medical costs among individuals with spina bifida, compared with those without, in Germany for the year 2009. Results: During the study period, there were 7478 documented cases of spina bifida and anencephaly among the 9,161,189 births, with an estimated average combined prevalence of 8.16 per 10,000 births (95% confidence interval, 7.98 - 8.35). For the 241 spina bifida-affected live births in 2009 in Germany, the estimated additional lifetime direct medical costs compared with non-spina bifida affected births were €65.5 million. Assuming a 50% reduction in the prevalence if folic acid has been provided to all women before pregnancy, 293 spina bifida cases could have been prevented in Germany in 2009. The estimated lifetime direct medical cost saving for the live births in 2009 was €32.9 million assuming a 50% reduction, or €26.1 million assuming a 40% risk reduction. Conclusion: Europe has an epidemic of spina bifida and anencephaly compared with countries with mandatory folic acid fortification policy. Primary prevention through mandatory folic acid fortification would considerably reduce the number of affected pregnancies, and associated additional costs.
URI: https://digitalcollection.zhaw.ch/handle/11475/12834
Volltext Version: Publizierte Version
Lizenz (gemäss Verlagsvertrag): Lizenz gemäss Verlagsvertrag
Departement: School of Management and Law
Organisationseinheit: Winterthurer Institut für Gesundheitsökonomie (WIG)
Enthalten in den Sammlungen:Publikationen School of Management and Law

Dateien zu dieser Ressource:
Es gibt keine Dateien zu dieser Ressource.
Zur Langanzeige
Obeid, R., Pietrzik, K., Oakley, G., Kancherla, V., Holzgreve, W., & Wieser, S. (2015). Preventable spina bifida and anencephaly in Europe. Birth Defects Research, 103(9), 763–771. https://doi.org/10.1002/bdra.23400
Obeid, R. et al. (2015) ‘Preventable spina bifida and anencephaly in Europe’, Birth Defects Research, 103(9), pp. 763–771. Available at: https://doi.org/10.1002/bdra.23400.
R. Obeid, K. Pietrzik, G. Oakley, V. Kancherla, W. Holzgreve, and S. Wieser, “Preventable spina bifida and anencephaly in Europe,” Birth Defects Research, vol. 103, no. 9, pp. 763–771, 2015, doi: 10.1002/bdra.23400.
OBEID, Rima, Klaus PIETRZIK, Godfrey OAKLEY, Vijaya KANCHERLA, Wolfgang HOLZGREVE und Simon WIESER, 2015. Preventable spina bifida and anencephaly in Europe. Birth Defects Research. 2015. Bd. 103, Nr. 9, S. 763–771. DOI 10.1002/bdra.23400
Obeid, Rima, Klaus Pietrzik, Godfrey Oakley, Vijaya Kancherla, Wolfgang Holzgreve, and Simon Wieser. 2015. “Preventable Spina Bifida and Anencephaly in Europe.” Birth Defects Research 103 (9): 763–71. https://doi.org/10.1002/bdra.23400.
Obeid, Rima, et al. “Preventable Spina Bifida and Anencephaly in Europe.” Birth Defects Research, vol. 103, no. 9, 2015, pp. 763–71, https://doi.org/10.1002/bdra.23400.


Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.